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Abstract
Background: Recent research suggests that several pathogenetic factors, including aging, genetics, inflammation,
dyslipidemia, diabetes, and infectious diseases, influence cognitive decline (CD) risk. However, no definitive
candidate causes have been identified. The present study evaluated whether certain serum parameters predict CD.
Methods: A total of 151 participants were assessed for CD using the Mini-Mental State Examination (MMSE), and 34
participants were identified as showing CD.
Results: Among CD predictive risk factors, Helicobacter pylori seropositivity was significantly predictive of CD risk, more
so than classical risk factors, including white matter lesions and arterial stiffness [adjusted odds ratio (OR) = 4.786, 95%
confidence interval (CI) = 1.710–13.39]. A multivariate analysis indicated that the albumin to globulin (A/G) ratio was the
only factor that significantly lowered CD risk (OR = 0.092, 95% CI = 0.010–0.887). A/G ratio also was positively correlated
with MMSE scores and negatively correlated with disruption of homeostatic factors (i.e., non-high-density lipoprotein,
hemoglobin A1c, and high-sensitive C-reactive protein).
Conclusions: The current study results suggest that the A/G ratio is related to cognitive decline and may reflect
homeostatic alterations.
Keywords: Albumin to globulin ratio, Cognitive decline, Helicobacter pylori, Homeostatic alteration, Mini-mental state
examination
Background
Improvements in health care support have greatly ex-
tended average life expectancy, resulting in a substantial
increase in the number of elderly individuals worldwide.
Some forms of memory impairment are observed among
elderly adults and can be predictive of age-related cogni-
tive decline associated with Alzheimer’s disease (AD) [1]
and other dementias. Rate of memory impairment varies
based on several factors, including age, sex, types of cog-
nitive tasks assessed, education, and emotional state [2].
Previous reports have noted several causes for cognitive
decline (CD). For instance, infection can cause both dir-
ect and indirect decrements. The association between
Helicobacter pylori (H. pylori) infection and AD has
recently been addressed [3], and other infections [i.e.,
Chlamydia pneumoniae (C. pneumoniae), cytomegalovirus,
and herpes simplex virus type1] may influence AD mani-
festation [4]. Furthermore, inflammation-mediated damage
in the apolipoprotein E (ApoE) allele 4 suggests a plausible
marker for cognitive impairment, possibly due to increased
viral replication, which could eventually lead to AD [5].
One way to affect this relationship is by controlling risk fac-
tors (e.g., diabetes, cholesterol, hypertension, stroke, or
smoking) that could help alleviate physiological dementia
risk factors [6]. A common factor is chronic and systemic
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inflammation, which leads to increased levels of several
proinflammatory cytokines that subsequently promote CD
progression [7]. Chronic and systemic inflammation also
induces atherosclerosis [8] and atherosclerosis-promoted
cognitive impairment [9].
There is growing interest in identifying individuals
who have not yet demonstrated CD but could be at
greater risk for developing dementia. This is because
cognitive impairment responds much better to treatment
during early compared to advanced illness stages. With
substantial increases in dementia incidence, early detec-
tion of possible precursors, diagnostics, treatment, and
control of modifiable risk factors are highly important
[10]. Insight is needed regarding the specific risk factors
that predict CD incidence. Elucidation of these factors
will help identify individuals with CD who are at the
highest risk for developing AD in the near future.
Thus, the aim of the present nested case control study
was to evaluate whether certain serum parameters, com-
monly measured during routine health checkups includ-
ing magnetic resonance imaging (MRI) and pulse wave
velocity as a marker of arterial stiffness, could be viable
predictors of CD incidence.
Methods
Study participants
The present study consisted of self-administered ques-
tionnaires and medical examinations, including blood
tests, conducted at the Kyoto Industrial Health Associ-
ation. From 2003 to 2004, 488 Japanese participants
completed a baseline epidemiological survey [11]. Basic
cognitive functioning was assessed for 273 participants
from 2006 to 2008 and for 290 participants from 2012
to 2014. A group of 151 participants (101 men and 50
women), with normal cognition in 2006–2008, attended
follow-up visits during both the 2006–2008 and 2012–
2014 periods. We included all of these 151 patients in
our study in order to avoid selection bias. The Ethics
Board from the Kyoto Prefectural University of Medicine
approved the study protocol (G-144). After we explained
the purpose of the study, written informed consent was
obtained from all participants.
Cognitive testing
The Mini-Mental State Examination (MMSE) is a brief,
but universal, 30-point measure of cognitive status [12].
The MMSE has become one of the most widely used
cognitive screening instruments for CD, which covers
various cognitive domains. Specifically, the MMSE is used
to estimate the severity of cognitive impairment and assess
longitudinal changes in cognitive status. Trained neurolo-
gists or a neuropsychologist determined the MMSE scores
as described previously [13]. A score ≤ 27 is considered
reflective of cognitive impairment [14]. We were able
to identify 34 participants as suitable for the CD group
as they produced MMSE scores between 28–30 points
in 2006–2008 and scores from 24–27 in 2012–2014.
Similarly, 117 participants were defined as the control
group, with scores from 28–30 in 2006–2008 that did
not decrease when assessed in 2012–2014. The time
between the two cognitive evaluations was not signifi-
cantly different between the control (mean = 5.74 years)
and CD (mean = 5.76 years) groups.
The verbal fluency test is a well-established method
for evaluation of cognitive function [15]. All participants
also completed a verbal fluency test. In this task, as in
previous reports, the participants were asked to provide
as many words beginning with Ta and Ka as they could
recall [13].
Medical information and blood biochemistry
The present study evaluated medical information ob-
tained via self-administered questionnaires (education
level, anamnesis at baseline and in 2012–2014, medica-
tion, frequency of depressive symptoms, smoking, and
drinking habits). Instrumental activities of daily living
(IADL) and metabolic equivalents (METs) were assessed
as previously reported [16, 17]. The scoring guidelines
recommend adding an additional point for people with
less than 13 years of education [18]. Furthermore, blood
chemistry data [triglycerides, total cholesterol, high-density
lipoprotein cholesterol (HDL-C), non-HDL-C, total protein,
albumin, A/G ratio, creatinine, uric acid, hemoglobin A1c
(HbA1c), high sensitive C-reactive protein (hsCRP), and
antibodies against C. pneumonia, and H. pylori antibodies]
were assessed. An IgG index above 1.1, and an IgA index
above 1.1, was defined as criteria for C. pneumoniae positiv-
ity [19], and a cutoff point greater than 2.3 for the ELISA
VALUE indicated H. pylori positivity [20]. The following
anthropometry data were also obtained during the health
check-ups: weight, height, and systolic and diastolic blood
pressure. Anamnesis and medication history were assessed
using a questionnaire. Hypertension was resting systolic
blood pressure ≥ 140 mmHg or being treated for hyperten-
sion. Diabetes mellitus was defined as HbA1c ≥ 6.5% and
dyslipidemia as triglycerides ≥ 150 or HDL ≤ 40. Addition-
ally, the pulse wave velocity [21], which is a potential
marker of arterial stiffness, was measured in 2006–2008
and 2012–2014.
Apolipoprotein E genotyping
Genomic DNA was extracted from the buffy coat frac-
tion of each participant’s blood sample. Genotyping was
performed using polymerase chain reaction (PCR) with
the following primers; forward: ACGAGACCATGAAG
GAGTTGAA and reverse: ACCTGCTCCTTCACCTCG
TCCAG. Amplification of the genomic DNA resulted in
a PCR product = 514 bp, which was subjected to a direct
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sequence or PCR-restriction fragment length poly-
morphism analysis [22]. The ApoE isoforms differed in
cysteine and arginine content at positions 112 and 158:
ApoE-ε2: Cys (TGC), Cys (TGC), ApoE-ε3: Cys (TGC),
Arg (CGC), ApoE-ε4: Arg (CGC), Arg (CGC). ApoE sta-
tus was classified as ε4 carriers for participants with the
ApoE4 isoform (phenotypes ε2/4, ε3/4, ε4/4) and as
non-4 carriers for participants without the ApoE4 iso-
form (phenotypes ε2/2, ε2/3, ε3/3).
Scoring white matter and periventricular hyperintensities
Brain MRI was performed using a 1.5-T scanner. MRI
was performed to assess different types of hyperintense
signal abnormalities surrounding the ventricles, and
deep white matter abnormalities were evaluated as deep
white matter lesions (DWL) and periventricular hyperin-
tensities (PVH), as previously reported [13]. MRI cere-
brovascular staging was carried out using the Fazekas
classification [23].
Statistical analyses
Continuous variables are expressed as means ± standard
deviations (SDs) or median [range], and categorical data
are expressed as sums and percentages. Inter-group
comparisons were performed using unpaired t-tests for
continuous variables or Mann–Whitney U-tests, and the
chi-square or Fisher’s exact tests for categorical variables
(sex, ApoE4, education, depressive symptoms, baseline
and 2012–2014 period anamnesis, C. pneumonia and H.
pylori seropositivity, drinking and smoking prevalence,
DWL, and PVH). Odds ratios (OR) and 95% confidence
intervals (CI) were calculated using logistic regression
analyses in which CD was the dependent variable and
age, sex, ApoE4 status, education, smoking and drinking
habits, and baseline anamnesis were the independent
variables. Significant predictors from the logistic regres-
sion analysis were considered independent variables in
the multiple logistic regression analysis using a stepwise
forward selection method. A Spearman’s rank correlation
coefficient was calculated to confirm whether serum A/G
ratio was related to MMSE scores, pulse wave velocity,
and hsCRP, as well as significant variables from the logistic
regression analysis. All statistical tests were two-tailed,
and differences with a p-value < 0.05 were considered sta-
tistically significant. SPSS software (version 18.0) was used
for all statistical analyses.
Results
Participant characteristics
Table 1 shows participant characteristics, including an-
thropometric measures, blood chemistry data, question-
naire responses, and the number for each item between
the control and CD groups. The mean age (± standard
deviation: SD) for the control group was 59.4 (±5.9)
years, compared to 61.2 (±4.6) years for the CD group.
There were no significant differences between the an-
thropometric measures of the two groups. Although the
CD group did not show significantly decreased scores on
verbal fluency tasks in 2006–2008, their verbal fluency
scores significantly decreased in 2012–2014. Further-
more, no significant differences in depressive symptoms,
IADL, or METs were observed between the control and
CD groups. The distribution of ApoE4 genotypes was in
the Hardy–Weinberg equilibrium (control group: p = 0.621;
CD group: p = 0.565). The ApoE4 allele distribution
was not significantly different between the control and
CD groups.
Associations between CD and control participant
characteristics
Non-HDL-C, total protein, HbA1c, H. pylori seropositiv-
ity, and pulse wave velocity during both 2006–2008 and
2012–2014 were significantly higher in the CD group
compared to the control group (Table 1). In contrast,
the A/G ratio was significantly lower in the CD group
(Table 1).
To determine variables significantly associated with CD,
a logistic regression analysis adjusted for age, sex, ApoE4
status, education, smoking and alcohol drinking habits,
and anamnesis was performed. The variables selected by
this analysis were MRI evaluation, body mass index (BMI),
systolic blood pressure (SBP), diastolic blood pressure
(DBP), triglycerides, total cholesterol, HDL, non-HDL,
total protein, albumin, A/G ratio, creatinine, uric acid,
HbA1c, hsCRP, C. pneumoniae and H. pylori seropositiv-
ity, pulse wave velocity, education, and ApoE4 status
(Tables 2 and 3). From a diagnostic imaging viewpoint
(Table 2), the odds of DWL grade 1 and 2, which were
evaluated by a Fazekas classification during the 2nd fol-
low-up, showed significant higher values for CD group. As
shown in Table 3, non-HDL-C, A/G ratio, HbA1c, and H.
pylori seropositivity were predictive of CD.
Next, a multivariate analysis was performed with all of
the significant variables considered simultaneously: non-
HDL-C, A/G ratio, HbA1c, and H. pylori seropositivity
(Table 4). Based on a stepwise forward selection method,
A/G ratio was significantly predictive with a low OR
(OR = 0.092, 95% CI = 0.010–0.887), and H. pylori sero-
positivity was significantly predictive with a high OR
(OR = 4.468, 95% CI = 1.535–13.00). Therefore, A/G ratios
were significantly positive correlation of MMSE scores
(during both 2006–2008 and 2012–2014), and negative cor-
relation with non-HDL-C, HbA1c, and hsCRP (Table 5).
Discussion
Although no single cause for cognitive impairment has
been identified, recent research suggests that several
pathogenetic factors such as aging, genetics, inflammation,
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dyslipidemia, diabetes, and infectious diseases are plaus-
ible candidates. The present results revealed that H. pylori
seropositivity tended to be related to more severe CD inci-
dence. Furthermore, the present study explored, for the
first time, an association between A/G ratios and CD
incidence.
Growing evidence has underscored a mechanistic link
between cholesterol metabolism in the brain and the for-
mation of amyloid plaques. Excess brain cholesterol has
been associated with increased formation and deposition
of β-amyloid from amyloid precursor proteins. Indeed,
non-HDL-C was associated with CD incidence in the
present study. Cholesterol-lowering statins have become
a focus for AD research [24]. Moreover, genetic poly-
morphisms associated with pivotal points in cholesterol
metabolism within brain tissues may contribute to AD
risk and pathogenesis. A recent meta-analysis indicated
the positive predictive value of the ApoE4 allele for pro-
gression from cognitive impairment to AD-type dementia
[25]. Although there is convincing evidence to suggest that
ApoE4 is the main predictor for progression from CD to
AD, ApoE4 may not be a risk factor for CD incidence. For
instance, the present findings revealed that ApoE4 status
was not associated with CD incidence.
Cognitive impairment can present with mild deficits
affecting one or multiple cognitive domains. Size and loca-
tion of white matter lesions and ischemic and hemorrhagic
strokes are associated with varying clinical presentation in
these patients [26]. Concerning the link between CD inci-
dence and cerebrovascular lesion occurrence, we found that
the CD group showed not only decreased MMSE scores
but also progression of DWL Fazekas grade. In general,
white matter lesions are a key vascular, cognitive impair-
ment marker. Although DWL and PVH were not predictive
of CD incidence in the present study, CD group indicated
DWL grade progression.
Recent studies have shown that H. pylori infection
leads to cognitive impairment [3]. H. pylori infection
likely influences cognitive impairment by increasing neu-
rodegenerative lesions, especially neurofibrillary tangles
Table 2 Logistic regression analysis according to CD condition
Number Model I Model II Model III
Control CD OR 95% CI OR 95% CI OR 95% CI
DWL Baseline
grade 0 67 17 Reference Reference Reference
grade 1 44 17 1.476 0.669-3.255 1.684 0.715-3.967 1.451 0.573-3.671
DWL 1st follow-up
grade 0 52 11 Reference Reference Reference
grade 1 55 20 1.764 0.754-4.129 1.872 0.759-4.619 1.763 0.697-4.455
grade 2 8 3 1.314 0.620-2.787 1.458 0.598-3.557 1.049 0.299-3.387
DWL 2nd follow-up
grade 0 43 5 Reference Reference Reference
grade 1 50 21 3.659 1.242-10.77 4.562 1.382-15.05 4.427 1.323-14.81
grade 2 17 7 2.058 1.042-4.062 3.969 1.424-11.06 4.215 1.384-12.83
grade 3 6 1 1.008 0.450-2.259 0.807 0.273-2.384 1.103 0.274-4.442
PVH Baseline
grade 0 83 23 Reference Reference Reference
grade 1 29 11 1.156 0.479-2.791 0.848 0.327-2.197 0.700 0.254-1.930
PVH 1st follow-up
grade 0 66 18 Reference Reference Reference
grade 1 41 15 1.152 0.498-2.668 0.971 0.392-2.409 0.909 0.359-2.298
grade 2 8 1 0.591 0.192-1.815 0.611 0.188-1.988 0.632 0.191-2.095
PVH 2st follow-up
grade 0 61 17 Reference Reference Reference
grade 1 44 13 0.857 0.354-2.075 0.847 0.337-2.131 0.857 0.337-2.175
grade 2 7 4 1.450 0.716-2.937 1.254 0.554-2.842 1.221 0.524-2.841
ModelI: Adjusted for age and sex
Model II: Adjusted for age, sex, apolipoprotein E4, education, smoking and alcohol drinking habits
Model III: Adjusted for age, sex, apolipoprotein E4, education, smoking and alcohol drinking habits, hypertension, hyperlipidemia and diabetes
CD cognitive decline, DWL white matter lesions, PVH perivascular hyperintensities, OR odds ratio, CI confidence interval
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and neuronal loss via ischemic lesions. H. pylori infection
evolving over many years could also cause chronic gastric
and plasmatic inflammation, thus inducing a chronic in-
flammation model plausibly responsible for cerebrovascular
lesions and the exacerbation of neurodegeneration [3].
Moreover, when accomplished, H. pylori eradication is
beneficial for improving cognitive and functional states
among patients, perhaps altering the progressive nature
of AD [27]. Additionally, chronic inflammation might be
an underlying factor for an association between metabolic
syndrome and CD [28]. The present study suggests a rela-
tionship between inflammation, disruption of homeostatic
factors [e.g., cholesterol metabolism (dyslipidemia), HbA1c
Table 3 Logistic regression analysis according to CD condition
Number Model I Model II Model III
Control CD OR 95% CI OR 95% CI OR 95% CI
BMI 117 34 1.073 0.998-1.154 1.060 0.910-1.235 1.024 0.868-1.207
SBP 117 34 0.999 0.938-1.151 0.994 0.971-1.017 0.971 0.941-1.002
DBP 117 34 1.010 0.970-1.052 0.998 0.954-1.044 0.997 0.941-1.036
Triglyceride 115 34 1.003 0.996-1.011 1.002 0.994-1.010 1.002 0.989-1.015
Total cholesterol 115 34 1.001 0.998-1.022 1.009 0.995-1.022 1.009 0.995-1.022
HDL-C 115 34 0.972 0.946-0.999 0.977 0.950-1.004 0.973 0.942-1.005
non-HDL-C 115 34 1.014 1.003-1.025 1.013 1.001-1.025 1.013 1.001-1.027
Total Protein 115 34 2.971 1.023-8.622 3.575 1.088-11.74 3.219 0.938-11.04
Albumin 115 34 2.035 0.291-14.21 1.980 0.243-16.12 1.852 0.218-15.71
A/G ratio 99 30 0.063 0.006-0.619 0.032 0.003-0.379 0.037 0.003-0.470
Creatinine 115 34 2.688 0.207-34.86 2.852 0.185-43.87 2.235 0.135-36.88
Uric acid 115 34 1.007 0.695-1.459 1.037 0.707-1.520 1.068 0.730-1.563
HbA1c 117 34 2.433 1.156-5.118 2.405 1.131-5.112 2.586 1.036-6.455
hsCRP 71 26 12.95 0.104-1617 66.97 0.303-14824 42.42 0.127-14225
C. pneumoniae seropositivity 117 34 1.297 0.580-2.899 1.437 0.619-3.336 1.593 0.664-3.82
H. pylori seropositive 117 34 3.507 1.398-8.801 4.867 1.754-13.50 4.786 1.710-13.39
Pulse wave velocity in 2006-2008 116 34 1.184 1.021-1.371 1.209 1.028-1.422 1.179 0.989-1.404
Pulse wave velocity in 2012-2014 116 34 1.158 1.015-1.322 1.145 0.989-1.327 1.125 0.963-1.313
Education 113 34 2.129 0.927-4.890
ApoE4 carrier 115 33 0.781 0.310-1.970
Model I: Adjusted for age and sex
Model II: Adjusted for age, sex, apolipoprotein E4, education, smoking and alcohol drinking habits
Model III: Adjusted for age, sex, apolipoprotein E4, education, smoking and alcohol drinking habits, hypertension, hyperlipidemia and diabetes
CD cognitive decline, OR odds ratio, CI confidence interval, A/G albumin to globulin, H. pylori Helicobacter pylori, C. pneumoniae Chlamydia pneumoniae, ApoE
apolipoprotein E, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin
A1c, hsCRP high sensitive C-reactive protein
Table 4 Multiple logistic regression analysis with stepwise
forward selection based on CD condition
Multivariate Stepwise forward selection
OR 95% CI OR 95% CI
non-HDL-C 1.011 0.999-1.024
A/G ratio 0.265 0.022-3.215 0.092 0.010-0.887
HbA1c 1.743 0.782-3.883
H. pylori seropositive 4.255 1.422-12.73 4.468 1.535-13.00
Sex 1.493 0.522-4.270
Age 1.079 0.983-1.183
CD cognitive decline, OR odds ratio, CI confidence interval, HDL-C high-density
lipoprotein cholesterol, HbA1c hemoglobin A1c, A/G albumin to globulin,
H. pylori: Helicobacter pylori




MMSE score in 2006-2008 0.187 0.034




Pulse wave velocity in 2006-2008 −0.047 0.598
Pulse wave velocity in 2012-2014 −0.001 0.989
A/G albumin to globulin, MMSE Mini-Mental State Examination, HDL-C high-
density lipoprotein cholesterol, HbA1c hemoglobin A1c, hsCRP high sensitive
C-reactive protein
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(diabetes), and H. pylori seropositivity (infectious disease)]
and cognitive function, since these inflammatory mech-
anisms are also hypothesized to be involved in the
pathogenesis of cognitive impairment. Furthermore, in-
flammation may also promote the development and
progression of atherosclerotic plaques [8], which is in
line with evidence suggesting a link between cognitive
impairment and atherosclerosis [9]. However, in the
present study, pulse wave velocity in 2006–2008 was not
predictive of CD. In other words, disruption of homeo-
static factors, in itself, was a more useful predictor of CD
incidence than arterial stiffness.
From a preventive viewpoint, albumin serves as an
antioxidant, eliminates toxins, and inhibits the formation
of amyloid beta-peptide fibrils. Several studies suggest
that low albumin levels are associated with a risk for
cognitive impairment and dementia [29, 30]. The present
study, however, observed that CD incidence was associ-
ated with A/G ratios but not albumin. In fact, albumin
levels did not differ between the control and CD groups.
Additionally, total protein levels trended toward a risk
for CD incidence, indicating that globulin levels were in-
creased in the CD group due to no difference in albumin
levels between the control and CD groups. Namely, A/G
ratios may decrease due to globulin levels rising during
chronic inflammation. Similarly, increased serum globulins
have been associated with cancer, rheumatoid diseases,
chronic liver disease, nephrotic syndrome, and diabetes
mellitus; decreased albumin has been associated with
chronic infections, chronic liver disease, and nephrotic
syndrome [31, 32]. Thus, it appears that the modification of
albumin and globulin is associated with disruption of
homeostasis. In the present study, A/G ratios were also sig-
nificantly and positively correlated with MMSE scores and
negatively correlated with cholesterol metabolism, HbA1c,
and hsCRP. These factors were decreased in relation to CD
incidence based on our stepwise regression analysis. In
sum, the A/G ratio may be a very reliable index for CD in-
cidence caused by disruption of homeostasis.
A few study limitations should be noted. First, there
were a relatively small number of participants in the CD
group. Therefore, an analysis of data from male and fe-
male participants separately would not be useful because
of the low statistical power. Although, the proportion of
male and female participants, and the education level of
the participants differed between the two groups, logistic
regression analysis was performed after adjusting for
these variables. While a study with low statistical power
has a reduced likelihood of detecting a true effect, nested
case–control studies with small sample sizes are still
widely conducted and can be used to identify candidate
targets. Secondly, we diagnosed H. pylori infections via
serum antibody detection, whereas the gold standard
involves gastric testing. The primary limitation of this
serologic test is its inability to discriminate between
current and old infections. However, H. pylori induces
humoral and cellular immune responses that can affect
or perpetuate neural tissue damage [33]. This pathogen
may influence the pathophysiology of AD by inducing
vascular disorders that have been implicated in endo-
thelial damage and neurodegeneration. Overall, the re-
sults of the present and previous studies suggest that
both current and old H. pylori infections contribute to
CD by inducing neural tissue damage. One other issue
was that A/G ratios, as well as other biological markers,
were only determined once, during the baseline survey.
Conversely, cognitive data were available at both base-
line and follow-up. Therefore, larger prospective trials
are needed to better assess how A/G ratios are associated
with CD incidence.
Conclusions
The current study observed that A/G ratios, which are
part of routinely administered laboratory tests, could re-
flect changes in homeostatic factors. Additional investi-
gations are expected to show that the modification of A/
G ratios could lead toward novel and effective strategies
for predictive CD screening.
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